Market analysis forecasts the global facial rejuvenation market will reach $5.66 billion by 2030, growing at a 10.2% compound annual growth rate from current levels. The projection encompasses injectables, energy devices, and surgical procedures, reflecting sustained practitioner and patient investment in aesthetic maintenance.
Market
Facial Rejuvenation Market Forecast to Hit $5.66B by 2030
10.2% CAGR projects sustained injectable and device demand through end of decade.
10.2% CAGR through 2030 signals sustained aesthetic spending.
The 10.2% CAGR outpaces general healthcare inflation, signaling that aesthetic spending is structural rather than cyclical. For practice owners, the data supports continued capital deployment into injectables and device infrastructure—particularly in underserved geographies where facial procedures remain underpenetrated. However, the forecast assumes no major disruption from GLP-1 weight-loss drugs or biosimilar toxin pricing compression. Practices should model downside scenarios where toxin unit economics compress further and filler volume shifts toward biostimulators and hybrid protocols.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.